BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 10654175)

  • 1. Subretinal fibrosis and choroidal neovascularization in Vogt-Koyanagi-Harada syndrome.
    Lertsumitkul S; Whitcup SM; Nussenblatt RB; Chan CC
    Graefes Arch Clin Exp Ophthalmol; 1999 Dec; 237(12):1039-45. PubMed ID: 10654175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal observation of subretinal fibrosis in Vogt-Koyanagi-Harada disease.
    Zhao C; Dong F; Gao F; Liu X; Pei M; Jia S; Zhang M
    BMC Ophthalmol; 2018 Jan; 18(1):6. PubMed ID: 29334924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subretinal fibrosis in patients with Vogt-Koyanagi-Harada disease.
    Kuo IC; Rechdouni A; Rao NA; Johnston RH; Margolis TP; Cunningham ET
    Ophthalmology; 2000 Sep; 107(9):1721-8. PubMed ID: 10964836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation of pseudodiscs in chronic recurrent Vogt-Koyanagi-Harada syndrome.
    Liao HR; Juang CJ
    Can J Ophthalmol; 1989 Oct; 24(6):280-2. PubMed ID: 2611713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optical coherence tomography in the acute and chronic phases of Vogt-Koyanagi-Harada disease.
    Parc C; Guenoun JM; Dhote R; Brézin A
    Ocul Immunol Inflamm; 2005; 13(2-3):225-7. PubMed ID: 16019683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in Vogt-Koyanagi-Harada syndrome.
    Farah ME; Costa RA; Muccioli C; Guia TA; Belfort R
    Am J Ophthalmol; 2002 Jul; 134(1):137-9. PubMed ID: 12095828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complications and prognostic factors in Vogt-Koyanagi-Harada disease.
    Read RW; Rechodouni A; Butani N; Johnston R; LaBree LD; Smith RE; Rao NA
    Am J Ophthalmol; 2001 May; 131(5):599-606. PubMed ID: 11336934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between retinal lesions and inward choroidal bulging in Vogt-Koyanagi-Harada disease.
    Hosoda Y; Uji A; Hangai M; Morooka S; Nishijima K; Yoshimura N
    Am J Ophthalmol; 2014 May; 157(5):1056-63. PubMed ID: 24491415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vogt-Koyanagi-Harada disease.
    Read RW; Rao NA; Cunningham ET
    Curr Opin Ophthalmol; 2000 Dec; 11(6):437-42. PubMed ID: 11141638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subretinal neovascular membranes in Vogt-Koyanagi-Harada syndrome.
    Moorthy RS; Chong LP; Smith RE; Rao NA
    Am J Ophthalmol; 1993 Aug; 116(2):164-70. PubMed ID: 8352300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinal cystoid spaces in acute Vogt-Koyanagi-Harada syndrome.
    Tsujikawa A; Yamashiro K; Yamamoto K; Nonaka A; Fujihara M; Kurimoto Y
    Am J Ophthalmol; 2005 Apr; 139(4):670-7. PubMed ID: 15808163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY FEATURES OF SUBRETINAL FIBROSIS AFTER MYOPIC NEOVASCULARIZATION.
    Milani P; Pellegrini M; Massacesi A; Scotti F; Moschini S; Setaccioli M; Secondi R; Bergamini F
    Retina; 2020 Feb; 40(2):249-256. PubMed ID: 31972794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect on choroidal changes of the route of systemic corticosteroids in acute Vogt-Koyanagi-Harada disease.
    Park UC; Cho IH; Lee EK; Yu HG
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1203-1211. PubMed ID: 28382438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vogt-Koyanagi-Harada syndrome (uveomeningoencephalitic syndrome).
    Manethova K; Ernest J; Hrevus M
    Eur J Ophthalmol; 2017 Jan; 27(1):e5-e8. PubMed ID: 28009404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multispectral image analysis in Vogt-Koyanagi-Harada disease.
    Huang G; Peng J; Ye Z; Kijlstra A; Zhang D; Yang P
    Acta Ophthalmol; 2018 Jun; 96(4):411-419. PubMed ID: 29220112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Annular choroidal detachment in a patient with Vogt-Koyanagi-Harada disease.
    Yamamoto N; Naito K
    Graefes Arch Clin Exp Ophthalmol; 2004 Apr; 242(4):355-8. PubMed ID: 14963715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilateral peripapillary choroidal neovascular membranes in Vogt-Koyanagi-Harada disease.
    Banerjee M; Kumar A; Azad SV; Chawla R
    BMJ Case Rep; 2024 Jun; 17(6):. PubMed ID: 38937264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultra-wide-field angiography findings in acute Vogt-Koyanagi-Harada disease.
    Kim P; Sun HJ; Ham DI
    Br J Ophthalmol; 2019 Jul; 103(7):942-948. PubMed ID: 30100554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vogt-Koyanagi-Harada disease.
    O'Keefe GA; Rao NA
    Surv Ophthalmol; 2017; 62(1):1-25. PubMed ID: 27241814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Choroidal and Retinal Anatomical Responses Following Systemic Corticosteroid Therapy in Vogt-Koyanagi-Harada Disease Using Swept-Source Optical Coherence Tomography.
    Jaisankar D; Raman R; Sharma HR; Khandelwal N; Bhende M; Agrawal R; Sridharan S; Biswas J
    Ocul Immunol Inflamm; 2019; 27(2):235-243. PubMed ID: 28700251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.